October 2018
TABLE OF CONTENTSCluster's lifeOur member's newsSave the dateCalls for projectsAround our themes

Collaborations, future medicine, medical technologies, European projects, international missions ... All topics discussed this October echo the 4.0 roadmap that the cluster has recently filed.

The month of November, meanwhile, will highlight member companies seeking private capital during the 10th Private Investments Day. Experts in nosocomial infections will meet during of the 10th edition of this event organized in collaboration with the FINOVI Foundation.

Cluster's life

 S3martMed, supporting interregional projects around medical technologiesSince October, 1st 2018 and for 24 months, Lyonbiopole coordinates a new European project, S3martMed, alongside the clusters BioPmed, Biowin, BioRegio Stern and MedSilesia and their regional authorities. This new initiative, co-funded by the COSME programme of the European Union, aims to create an alliance of clusters to support the emergence of innovative projects in the field of medical technologies between SMEs and research centres, by improving access to key technologies. Once the projects identified, the aim will be to define together with the regional authorities the future Investment Scenarios. [...]
 Lyonbiopole accelerates collaboration between innovative companies from AURA and JapanAs part of its International Development Plan funded by the Auvergne-Rhône-Alpes Region, Lyonbiopole conducted, with the support of Business France a mission to Japan as part of the BioJapan, for the 5th year running. [...]
 Prospective themes and future medicine, part of Lyonbiopole Collaborative Day programThe 12th edition of Lyonbiopole's Collaborative Day was held at the WTC in Grenoble on October 18 and brought together about 200 participants. This Lyonbiopole's scientific event deals with prospective themes every year. […]
 1st international nutrition and health mission in QuebecIn order to reinforce its action in the field of health nutrition, Lyonbiopole organized its first mission on the occasion of the BENEFIQ Congress in Quebec City. Three innovative companies from the Auvergne-Rhône-Alpes region were present: AMA RESEARCH SOLUTIONS, RECOVERLAB, and PILEJE. [...]
 Lyonbiopole in actionDiscover Lyonbiopole's action in videos: testimonies of speakers and a video key figures around the Skin Aging Day; 5 interventions to highlight the 10th edition, to come, of the Nosocomial Infections Day. [...]
 Lyonbiopole's Technical Group opens to EuropeIn its phase 4.0, Lyonbiopole’s mission will be to support its members more closely in setting up European projects.   Thus, the experts of the Technical Group (GTECH) of Lyonbiopole, who usually evaluate R&D projects at national level, will now be mobilized to audition the European projects applicants. During these hearing […]
 Innovation in skin biologyLyonbiopole and the CED have joined forces to organisea day dedicated to innovation in skin biology, as part of the regional initiative AURA Skin Biology Network*. The event brought together more than 120 participants (compared to 90 last year), 35% of whom were from outside Auvergne-Rhône-Alpes and in which most of the major national cosmetology groups were involved. [...]

Our member's news

 New members    MODJAW Tech in Motion is a medical device conceived by dentists for dentists. It allows the dentist to reach unparalleled knowledge of the dentition and the occlusion of the patient and paves the way for a brand-new dentistry. REAL-TIME 4D models (dynamic 3D) are at your fingertips within […]
 New members  MagIA diagnostics develops a highly innovative and generic point of care technology allowing for rapid immunoanalysis onto a portable system. Based on a patented technology developed by CNRS and Grenoble INP, MagIA performs a no-wash immunoassay using nanoparticles attracted onto embedded micro-magnets. This no-wash immunoassay drastically simplifies ELISA usually […]
 New membersSince January 1, 2000, EFS has been the only civil transfusion operator in France, under the supervision of the Ministry of Solidarity and Health.Its main missions are to ensure self-sufficiency in blood products across the country, to guarantee the safety of the transfusion chain, [...]
 Focus onORPHELIA Pharma, a French biopharmaceutical company dedicated to the development and marketing of pediatric drugs in the fields of oncology and neurology, announces today that the European Commission has granted Kigabeq® a European marketing authorization. [...]
 October 1st, 2018ORPHELIA Pharma: Granting of the marketing authorization for Kigabeq® October 3th, 2018Novasep opens at a cost of 27m¤ new Viral Vector Commercial Production Facility October 4th, 2018Poxel presents Complete PXL770 Phase 1 Results
 October 8th, 2018Orega Biotech: Interleukin-17 patent granted in Europe October 9th, 2018Theranexus announces a new European patent October 12th, 2018Adocia informs about a civil action filed by Eli Lilly
 October 12th, 2018Theranexus announces that R. BESSERVE will join its board of directors October 15th, 2018MaaT Pharma Announces First Patient Dosed in Phase 2 Clinical Trial October 16th, 2018Biom'up announces a first distribution agreement in Europe
 October 24th, 2018ORPHELIA Pharma has been awarded a 1M¤ loan from Bpifrance October 29th, 2018Theranexus announces inclusion of the last patient in phase II trial of drug candidate THN102 October 29th, 2018CMI’nov is the winner of a SME Instrument Phase 1 project
 October 29th, 2018VALBIOTIS confirms its interest in the study of the intestinal microbiota

Save the date

 10th Nosocomial Infections Day
November 20th, 2018
Private Inv¤stments Day 2018
November 30th, 2018
  • Immunotherapies for Infectious Diseases Congress 2018 (I4ID 2018)
    Décember 10th, 2018

  • See All events

    Calls for projects



  • Join TaNeDS Global 2019
    Before October 30th, 2018
  • SME Instrument (phase 1)
    Before November 7th, 2018
  • H2020 Health / Call – Trusted digital solutions and Cybersecurity in Health and Care
    Before November 14th, 2018
  • SME Instrument (phase 2)
    Before January 9th, 2019
  • Eurostars 2
    Before February 28th, 2019
  • H2020 Health / Call – Digital transformation in Health and Care
    Before April 24th, 2019
  • Around our themes

  • Scientific Workshop : Biomarkers of functional cure of Hepatitis B
    Décember 11th, 2018
  • Bâtiment Domilyon

    321, avenue Jean Jaurès

    69007 Lyon

    Tel. : +33 (0)4 72 76 53 30

    Fax : +33 (0)9 55 91 30 26





    This email has been sent automatically to [[EMAIL_TO]]. Click here to unsubscribe.